195 related articles for article (PubMed ID: 37808160)
1. Inhibition of insulin-degrading enzyme in human neurons promotes amyloid-β deposition.
Rowland HA; Moxon SR; Corbett NJ; Hanson K; Fisher K; Kellett KAB; Hooper NM
Neuronal Signal; 2023 Dec; 7(4):NS20230016. PubMed ID: 37808160
[TBL] [Abstract][Full Text] [Related]
2. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes.
Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K
Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983
[TBL] [Abstract][Full Text] [Related]
3. Oxidative inactivation of amyloid beta-degrading proteases by cholesterol-enhanced mitochondrial stress.
de Dios C; Bartolessis I; Roca-Agujetas V; Barbero-Camps E; Mari M; Morales A; Colell A
Redox Biol; 2019 Sep; 26():101283. PubMed ID: 31376793
[TBL] [Abstract][Full Text] [Related]
4. Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications.
Jha NK; Jha SK; Kumar D; Kejriwal N; Sharma R; Ambasta RK; Kumar P
J Alzheimers Dis; 2015; 48(4):891-917. PubMed ID: 26444774
[TBL] [Abstract][Full Text] [Related]
5. Modelling Alzheimer's disease in a dish: dissecting amyloid-β metabolism in human neurons.
Hill E; Cunningham TJ
Neuronal Signal; 2024 Jan; 8(1):NS20230020. PubMed ID: 38222463
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin and atorvastatin facilitates amyloid β-protein degradation in extracellular spaces by increasing neprilysin secretion from astrocytes through activation of MAPK/Erk1/2 pathways.
Yamamoto N; Fujii Y; Kasahara R; Tanida M; Ohora K; Ono Y; Suzuki K; Sobue K
Glia; 2016 Jun; 64(6):952-62. PubMed ID: 26875818
[TBL] [Abstract][Full Text] [Related]
7. Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain.
Wang S; Wang R; Chen L; Bennett DA; Dickson DW; Wang DS
J Neurochem; 2010 Oct; 115(1):47-57. PubMed ID: 20663017
[TBL] [Abstract][Full Text] [Related]
8. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
9. Leptin inhibits amyloid β-protein degradation through decrease of neprilysin expression in primary cultured astrocytes.
Yamamoto N; Tanida M; Ono Y; Kasahara R; Fujii Y; Ohora K; Suzuki K; Sobue K
Biochem Biophys Res Commun; 2014 Feb; 445(1):214-7. PubMed ID: 24508800
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin gallate induces extracellular degradation of amyloid β-protein by increasing neprilysin secretion from astrocytes through activation of ERK and PI3K pathways.
Yamamoto N; Shibata M; Ishikuro R; Tanida M; Taniguchi Y; Ikeda-Matsuo Y; Sobue K
Neuroscience; 2017 Oct; 362():70-78. PubMed ID: 28844000
[TBL] [Abstract][Full Text] [Related]
11. Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease.
Lauer AA; Mett J; Janitschke D; Thiel A; Stahlmann CP; Bachmann CM; Ritzmann F; Schrul B; Müller UC; Stein R; Riemenschneider M; Grimm HS; Hartmann T; Grimm MOW
Aging Cell; 2020 Nov; 19(11):e13264. PubMed ID: 33128835
[TBL] [Abstract][Full Text] [Related]
12. Characterization of insulin-degrading enzyme-mediated cleavage of Aβ in distinct aggregation states.
Hubin E; Cioffi F; Rozenski J; van Nuland NA; Broersen K
Biochim Biophys Acta; 2016 Jun; 1860(6):1281-90. PubMed ID: 26968463
[TBL] [Abstract][Full Text] [Related]
13. The effect of amyloid associated proteins on the expression of genes involved in amyloid-β clearance by adult human astrocytes.
Mulder SD; Veerhuis R; Blankenstein MA; Nielsen HM
Exp Neurol; 2012 Jan; 233(1):373-9. PubMed ID: 22101005
[TBL] [Abstract][Full Text] [Related]
14. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders.
Caccamo A; Oddo S; Sugarman MC; Akbari Y; LaFerla FM
Neurobiol Aging; 2005 May; 26(5):645-54. PubMed ID: 15708439
[TBL] [Abstract][Full Text] [Related]
15. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
16. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease.
Jean L; Thomas B; Tahiri-Alaoui A; Shaw M; Vaux DJ
PLoS One; 2007 Jul; 2(7):e652. PubMed ID: 17653279
[TBL] [Abstract][Full Text] [Related]
17. p75NTR regulates Abeta deposition by increasing Abeta production but inhibiting Abeta aggregation with its extracellular domain.
Wang YJ; Wang X; Lu JJ; Li QX; Gao CY; Liu XH; Sun Y; Yang M; Lim Y; Evin G; Zhong JH; Masters C; Zhou XF
J Neurosci; 2011 Feb; 31(6):2292-304. PubMed ID: 21307265
[TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
[TBL] [Abstract][Full Text] [Related]
19. Toward prevention of Alzheimers disease--potential nutraceutical strategies for suppressing the production of amyloid beta peptides.
McCarty MF
Med Hypotheses; 2006; 67(4):682-97. PubMed ID: 16828233
[TBL] [Abstract][Full Text] [Related]
20. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
